FDA signs off on Phase 1/2 study of Celsion's GEN-1 in ovarian cancer; shares ahead 24% premarket [Seeking Alpha]
Celsion Corporation (CLSN)
Last celsion corporation earnings: 11/14 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.celsion.com/investor-relations
Company Research
Source: Seeking Alpha
FDA signs off on Phase 1/2 study of Celsion's GEN-1 in ovarian cancer; shares ahead 24% premarketNano cap Celsion (NASDAQ:CLSN) is up24% premarket on increased volume on the heels of itsannouncement that the FDA is on board with its Phase 1/2 clinical trial assessing DNA-based immunotherapeutic GEN-1 for the localized treatment of ovarian cancer. Enrollment should commence in H1 with 25% of the target participating by year-end.GEN-1 is an interleukin 12 (IL-12) DNA plasmid vector encased in a nanoparticle delivery system, a technology platform the company callsTheraPlas. It is designed to stimulate the local production and secretion of IL-12, a potent inducer of anti-cancer immunity, around the tumor site.See all stocks on the move »Now read:What The Cell Design Labs Acquisition Means For Gilead? »
Show less
Read more
Impact Snapshot
Event Time:
CLSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLSN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLSN alerts
High impacting Celsion Corporation news events
Weekly update
A roundup of the hottest topics